Yes, Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) typically provides pre-audit notifications for drug quality audits. This process involves informing the pharmaceutical company about the upcoming audit, allowing them to prepare necessary documentation and personnel. The notification aims to ensure compliance and facilitate a smooth audit process, enhancing drug quality assurance.